[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:ewing-sarcoma":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":309,"states":320},"Ewing Sarcoma",52,48,[8,16,22,28,35,41,48,54,60,66,71,77,83,89,95,101,107,113,119,125,131,137,143,149,155,161,167,173,179,185,190,196,202,208,214,221,227,233,238,244,249,254,260,266,272,278,284,290,296,303],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06892678","DFMO Maintenance for Patients With Relapsed\u002FRefractory Ewing Sarcoma or Osteosarcoma",[12],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:18:30.351130Z","2026-07-05T05:32:16.700101Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT07188532","Biologically-Adapted, Dose-Escalated Radiotherapy for the Treatment of Ewing Sarcoma, BEAR Trial",[],"2026-08-26T02:16:59.895916Z","2026-07-05T05:32:16.657086Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT05734066","Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed\u002FRefractory Ewing Sarcoma",[12],"2026-08-26T02:17:34.833510Z","2026-05-05T02:43:27.924408Z",{"nct_id":29,"title":30,"phases":31,"status":13,"updated_at":33,"content_modified":34},"NCT07194044","Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes",[32],"Phase 1","2026-08-26T02:18:31.944757Z","2026-05-05T02:43:26.981537Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":39,"content_modified":40},"NCT03715933","Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas",[32],"2026-08-26T02:15:20.225313Z","2026-07-05T05:32:16.772905Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":46,"content_modified":47},"NCT07321912","Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma",[45],"Phase 2","2026-08-26T02:17:22.949982Z","2026-05-29T15:36:40.187051Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":52,"content_modified":53},"NCT07172958","Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed\u002FRefractory Embryonal Tumors (SABRE)",[32],"2026-08-26T02:15:26.669629Z","2026-05-05T02:43:29.230684Z",{"nct_id":55,"title":56,"phases":57,"status":13,"updated_at":58,"content_modified":59},"NCT07193550","A Phase 2 Trial of Zanzalintinib in Advanced\u002FMetastatic Bone Sarcomas (ZAMBONE)",[45],"2026-08-26T02:16:35.654046Z","2026-05-05T02:43:28.850363Z",{"nct_id":61,"title":62,"phases":63,"status":13,"updated_at":64,"content_modified":65},"NCT06156410","Cabozantinib With Ifosfamide in Relapsed\u002FRefractory Sarcomas",[32],"2026-08-26T02:17:18.747857Z","2026-05-05T02:43:28.669008Z",{"nct_id":67,"title":68,"phases":69,"status":13,"updated_at":39,"content_modified":70},"NCT05210374","Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas",[32],"2026-05-05T02:43:27.805890Z",{"nct_id":72,"title":73,"phases":74,"status":13,"updated_at":75,"content_modified":76},"NCT05918640","Lurbinectedin in FET-Fused Tumors",[12],"2026-08-26T02:19:19.975067Z","2026-05-05T02:43:26.725098Z",{"nct_id":78,"title":79,"phases":80,"status":13,"updated_at":81,"content_modified":82},"NCT05634369","A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue",[12],"2026-08-26T02:17:41.695983Z","2026-05-05T02:35:31.762190Z",{"nct_id":84,"title":85,"phases":86,"status":13,"updated_at":87,"content_modified":88},"NCT06571734","XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma, Bone Sarcoma or Translocation-associated Soft Tissue Sarcoma",[45],"2026-08-26T02:17:14.343713Z","2026-07-05T05:32:16.766529Z",{"nct_id":90,"title":91,"phases":92,"status":13,"updated_at":93,"content_modified":94},"NCT06625190","Alpha\u002FBeta T and B Cell Depletion With Zoledronic Acid for Solid Tumors",[12],"2026-08-26T02:19:04.543908Z","2026-07-05T03:45:20.453806Z",{"nct_id":96,"title":97,"phases":98,"status":13,"updated_at":99,"content_modified":100},"NCT06541262","Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors",[12],"2026-08-26T02:16:21.385056Z","2026-07-05T03:45:20.453347Z",{"nct_id":102,"title":103,"phases":104,"status":13,"updated_at":105,"content_modified":106},"NCT06465199","Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas",[12],"2026-08-26T02:15:58.452248Z","2026-06-16T05:54:07.918391Z",{"nct_id":108,"title":109,"phases":110,"status":13,"updated_at":111,"content_modified":112},"NCT04449549","Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel",[45],"2026-08-26T02:18:19.586423Z","2026-05-05T02:43:29.402368Z",{"nct_id":114,"title":115,"phases":116,"status":13,"updated_at":117,"content_modified":118},"NCT02508038","Alpha\u002FBeta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors",[32],"2026-08-26T02:17:26.640202Z","2026-05-05T02:43:29.192915Z",{"nct_id":120,"title":121,"phases":122,"status":13,"updated_at":123,"content_modified":124},"NCT04851119","Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors",[12],"2026-08-26T02:16:41.943926Z","2026-05-05T02:43:29.139986Z",{"nct_id":126,"title":127,"phases":128,"status":13,"updated_at":129,"content_modified":130},"NCT05135975","A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors",[45],"2026-08-26T02:16:46.147215Z","2026-05-05T02:43:28.530799Z",{"nct_id":132,"title":133,"phases":134,"status":13,"updated_at":135,"content_modified":136},"NCT04308330","Vorinostat in Combination With Chemotherapy in Relapsed\u002FRefractory Solid Tumors and CNS Malignancies",[32],"2026-08-26T02:19:10.436356Z","2026-05-05T02:43:28.511395Z",{"nct_id":138,"title":139,"phases":140,"status":13,"updated_at":141,"content_modified":142},"NCT04897321","B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)",[32],"2026-08-26T02:16:45.157238Z","2026-05-05T02:43:28.511090Z",{"nct_id":144,"title":145,"phases":146,"status":13,"updated_at":147,"content_modified":148},"NCT06500819","Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed\u002FRefractory Solid Tumors",[32],"2026-08-26T02:18:39.640967Z","2026-05-05T02:43:28.289390Z",{"nct_id":150,"title":151,"phases":152,"status":13,"updated_at":153,"content_modified":154},"NCT06395103","Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A\u002FLIGHTBEAM-U01)",[12],"2026-08-26T02:17:43.321968Z","2026-05-05T02:43:28.012234Z",{"nct_id":156,"title":157,"phases":158,"status":13,"updated_at":159,"content_modified":160},"NCT04995003","HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma",[32],"2026-08-26T02:16:31.714843Z","2026-05-05T02:43:27.987147Z",{"nct_id":162,"title":163,"phases":164,"status":13,"updated_at":165,"content_modified":166},"NCT05238792","Multi Tumor-Associated Antigen-Specific T Lymphocytes to Treat Patients With High Risk Solid Tumors",[32],"2026-08-26T02:19:28.327680Z","2026-05-05T02:43:27.959678Z",{"nct_id":168,"title":169,"phases":170,"status":13,"updated_at":171,"content_modified":172},"NCT02390752","Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...",[32],"2026-08-26T02:17:48.768272Z","2026-05-05T02:43:27.488578Z",{"nct_id":174,"title":175,"phases":176,"status":13,"updated_at":177,"content_modified":178},"NCT01804634","Reduced Intensity Haploidentical BMT for High Risk Solid Tumors",[45],"2026-08-26T02:15:50.539717Z","2026-05-05T02:43:27.448232Z",{"nct_id":180,"title":181,"phases":182,"status":13,"updated_at":183,"content_modified":184},"NCT07197554","A Phase 1\u002F1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies",[32],"2026-08-26T02:18:40.612983Z","2026-05-05T02:43:27.425950Z",{"nct_id":186,"title":187,"phases":188,"status":13,"updated_at":171,"content_modified":189},"NCT07222735","Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed\u002FRefractory Sarcomas",[32],"2026-05-05T02:43:27.273704Z",{"nct_id":191,"title":192,"phases":193,"status":13,"updated_at":194,"content_modified":195},"NCT05253131","Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas",[45],"2026-08-26T02:15:37.042762Z","2026-05-05T02:43:27.251035Z",{"nct_id":197,"title":198,"phases":199,"status":13,"updated_at":200,"content_modified":201},"NCT06709495","Phase 1\u002F2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas",[12],"2026-08-26T02:16:24.135291Z","2026-05-05T02:43:27.245630Z",{"nct_id":203,"title":204,"phases":205,"status":13,"updated_at":206,"content_modified":207},"NCT04469530","Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors",[45],"2026-08-26T02:18:49.989941Z","2026-05-05T02:43:27.107017Z",{"nct_id":209,"title":210,"phases":211,"status":13,"updated_at":212,"content_modified":213},"NCT04901702","Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma",[12],"2026-08-26T02:18:32.765187Z","2026-05-05T02:35:31.688370Z",{"nct_id":215,"title":216,"phases":217,"status":13,"updated_at":219,"content_modified":220},"NCT02446431","Metronomic Therapy for Pediatric Patients With Solid Tumors at High Risk of Recurrence",[218],"Early Phase 1","2026-08-26T02:16:12.203827Z","2026-05-05T02:43:28.295351Z",{"nct_id":222,"title":223,"phases":224,"status":13,"updated_at":225,"content_modified":226},"NCT04199741","PET\u002FCT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56",[12],"2026-08-26T02:18:04.640417Z","2026-07-05T05:32:16.773657Z",{"nct_id":228,"title":229,"phases":230,"status":13,"updated_at":231,"content_modified":232},"NCT06387485","A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning",[],"2026-08-26T02:18:34.622081Z","2026-05-05T02:43:28.883449Z",{"nct_id":234,"title":235,"phases":236,"status":13,"updated_at":135,"content_modified":237},"NCT04084067","Indocyanine Green (ICG) Guided Tumor Resection",[32],"2026-05-05T02:43:28.715739Z",{"nct_id":239,"title":240,"phases":241,"status":13,"updated_at":242,"content_modified":243},"NCT06235125","Safety and Feasibility of Intraoperative Visualization With Cytalux in Children",[32],"2026-08-26T02:16:02.918558Z","2026-05-05T02:43:27.069602Z",{"nct_id":245,"title":246,"phases":247,"status":13,"updated_at":200,"content_modified":248},"NCT03442465","Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas",[],"2026-05-13T02:55:06.124870Z",{"nct_id":250,"title":251,"phases":252,"status":13,"updated_at":206,"content_modified":253},"NCT07698899","A Study of 177Lu-DTPA-Omburtamab in Children and Adolescents With Brain Cancer or Cancer That Has Spread to the Central Nervous System (CNS)",[32],"2026-07-19T19:36:05.081790Z",{"nct_id":255,"title":256,"phases":257,"status":13,"updated_at":258,"content_modified":259},"NCT05033288","Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone",[],"2026-08-26T02:17:15.156099Z","2026-05-13T02:55:06.280317Z",{"nct_id":261,"title":262,"phases":263,"status":13,"updated_at":264,"content_modified":265},"NCT01050296","Molecular Analysis Of Solid Tumors",[],"2026-08-26T02:18:18.766496Z","2026-05-13T02:55:06.067848Z",{"nct_id":267,"title":268,"phases":269,"status":13,"updated_at":270,"content_modified":271},"NCT07297979","Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)",[32],"2026-08-26T02:15:39.267524Z","2026-05-05T02:43:29.644318Z",{"nct_id":273,"title":274,"phases":275,"status":13,"updated_at":276,"content_modified":277},"NCT07048249","Single Arm Romiplostim to Prevent CIT",[218],"2026-08-26T02:18:42.501841Z","2026-05-05T02:43:29.479784Z",{"nct_id":279,"title":280,"phases":281,"status":13,"updated_at":282,"content_modified":283},"NCT06796543","Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma",[],"2026-08-26T02:19:14.560989Z","2026-04-29T02:57:57.116969Z",{"nct_id":285,"title":286,"phases":287,"status":13,"updated_at":288,"content_modified":289},"NCT07628634","Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w\u002F Solid Tumors",[218],"2026-08-26T02:18:00.873391Z","2026-06-06T00:48:49.527814Z",{"nct_id":291,"title":292,"phases":293,"status":13,"updated_at":294,"content_modified":295},"NCT07514819","Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma",[],"2026-08-26T02:19:08.862440Z","2026-05-05T02:43:26.679931Z",{"nct_id":297,"title":298,"phases":299,"status":300,"updated_at":301,"content_modified":302},"NCT07695311","EWSR1 Immunotherapy in Ewing Sarcoma and DSRCT",[32],"NOT_YET_RECRUITING","2026-08-26T02:15:01.639696Z","2026-07-19T19:36:05.175768Z",{"nct_id":304,"title":305,"phases":306,"status":300,"updated_at":307,"content_modified":308},"NCT07516353","my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults",[],"2026-08-26T02:16:01.079019Z","2026-05-05T02:43:29.524607Z",[310,314,317],{"biomarker":311,"count":312,"slug":313},"CD276 wt Allele",3,"cd276-wt-allele",{"biomarker":315,"count":312,"slug":316},"EWSR1 Gene","ewsr1-gene",{"biomarker":318,"count":312,"slug":319},"HLA Complex","hla-complex",[321,325,329,333,337,341,345,349,353,356,359,363,366,369,372,376,379,382,386,389,393,396],{"state":322,"count":323,"slug":324},"California",17,"california",{"state":326,"count":327,"slug":328},"New York",16,"new-york",{"state":330,"count":331,"slug":332},"Tennessee",15,"tennessee",{"state":334,"count":335,"slug":336},"Texas",14,"texas",{"state":338,"count":339,"slug":340},"Pennsylvania",13,"pennsylvania",{"state":342,"count":343,"slug":344},"Ohio",12,"ohio",{"state":346,"count":347,"slug":348},"Florida",9,"florida",{"state":350,"count":351,"slug":352},"Arizona",8,"arizona",{"state":354,"count":351,"slug":355},"District of Columbia","district-of-columbia",{"state":357,"count":351,"slug":358},"Massachusetts","massachusetts",{"state":360,"count":361,"slug":362},"Alabama",7,"alabama",{"state":364,"count":361,"slug":365},"Georgia","georgia",{"state":367,"count":361,"slug":368},"Michigan","michigan",{"state":370,"count":361,"slug":371},"Missouri","missouri",{"state":373,"count":374,"slug":375},"Colorado",6,"colorado",{"state":377,"count":374,"slug":378},"Minnesota","minnesota",{"state":380,"count":374,"slug":381},"Utah","utah",{"state":383,"count":384,"slug":385},"Maryland",5,"maryland",{"state":387,"count":384,"slug":388},"New Jersey","new-jersey",{"state":390,"count":391,"slug":392},"Connecticut",4,"connecticut",{"state":394,"count":391,"slug":395},"Illinois","illinois",{"state":397,"count":312,"slug":398},"North Carolina","north-carolina"]